SCHEMBL6948821

SCHEMBL6948821

Nc1ncc2nc(Cc3ccccc3[N+](=O)[O-])[nH]c2n1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.40
EGFR P00533 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
AR P10275 1/20 0.39
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
PRKCQ Q04759 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
MGMT P16455 1/20 0.37
CLK1 P49759 2/20 0.36
DHFR P00374 1/20 0.36
RIPK1 Q13546 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949057 0.77 RIPK1 (0.50) MAPTEGFRALDH1A1TSHRRIPK1
SCHEMBL6944405 0.72 F2 (0.48) MAPTCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL6948190 0.71 KRAS (0.40) MAPTEGFRDHFR
SCHEMBL6948823 0.69 HDAC6 (0.47) MAPTEGFRCYP1A2ALDH1A1
SCHEMBL6948818 0.69 CYP1A2 (0.50) MAPTEGFRCYP1A2CYP3A4CYP2D6
SCHEMBL6950878 0.69 RAB9A (0.53) MAPTALDH1A1
SCHEMBL6946589 0.69 MAPT (0.37) MAPTCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL301933 0.67 ALDH1A1 (0.69) ARALDH1A1TSHRL3MBTL1
SCHEMBL10842287 0.67 AR (0.50) MAPTCYP1A2CYP3A4CYP2C19AR
SCHEMBL10956103 0.67 ADRA2A (0.52) CYP1A2CYP3A4CYP2D6CYP2C19AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1349857-A1 PURINE DERIVATIVES AS PURINERGIC RECEPTOR ANTAGONISTS VERNALIS RESEARCH LIMITED (GB) 2003-10-08 EP disclosed
WO-2002055521-A1 PURINE DERIVATIVES AS PURINERGIC RECEPTOR ANTAGONISTS VERNALIS RESEARCH LIMITED (GB) 2002-07-18 WO disclosed